Pylephlebitis cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Changes made per Mahshid's request)
 
Line 15: Line 15:
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Infectious disease]]
 


{{WS}}
{{WS}}
{{WH}}
{{WH}}

Latest revision as of 18:50, 18 September 2017

Pylephlebitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pylephlebitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pylephlebitis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pylephlebitis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pylephlebitis cost-effectiveness of therapy

CDC on Pylephlebitis cost-effectiveness of therapy

Pylephlebitis cost-effectiveness of therapy in the news

Blogs on Pylephlebitis cost-effectiveness of therapy

Directions to Hospitals Treating Pylephlebitis

Risk calculators and risk factors for Pylephlebitis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Cost-effectiveness of Therapy

References


Template:WS Template:WH